We found 11 online brokers that are appropriate for Trading Stocks Investment Platforms.
The COVID-19 pandemic is not over. New strains have invaded across the United Kingdom, Scotland, Germany and several more countries. While vaccines have been rolled out lately, it is still unpredictable whether the success rate would be high. Furthermore, experts believe that it would still be years before the pandemic will be over even with the vaccine.
Therefore for investors who are looking to invest in high risk and high reward stocks now, investing into companies dealing with drug development is a good strategy. In this article, we will discuss three companies specialising in drug development that can be invested into.
Listed as JNCE in NASDAQ, the Jounce Therapeutics cancer immunotherapy company has the potential of becoming lucrative as due to the high demand for its products. Furthermore, it has also lined up some projects in the pipeline which might further boost the profitability of the company.
The therapies of Jounce Therapeutics focus on affecting the tumor microenvironment (TME). This is an area inside the tumor and is traditionally difficult to treat with chemotherapy or other such first-line therapeutic methods.
Although Jounce Therapeutics is working on a highly lucrative area, the company also has competitors. The therapy is being developed by a couple of other companies, but is less specialized. This leaves the company with a competitive advantage where patients will be able to experience tangible benefits if the project is successful.
However, the stocks of Jounce Therapeutics is risky as there have been many companies which failed at the area where Jounce is attempting to breakthrough. The company therefore needs to buck this trend, which is highly difficult but not impossible.
Listed as RUBY on NASDAQ, Rubius Therapeutics deserves a watch list. It aims to genetically engineer red blood cells to serve as medicines for cancer and other critical illnesses.
A handful of other biotech companies are also in the process of developing cell therapies for the same purpose, but Rubius offers engineered red blood cells. Red blood cell therapy is believed to be more effective than other types of cells, but the project also comes with high risk.
Investors who wish to consider Rubius should also take note of its costly setbacks like the termination of the RTX-134 program for phenylketonuria and delays in the manufacturing operations throughout 2019. Hence, the nature of Rubius stocks is also considered to be high risk high reward.
Third in the list of high risk high reward stocks to discuss here is Sorrento Therapeutics. It is listed as SRNE on NASDAQ and has lately been in the news for developing coronavirus diagnostic tests and running in the race of coronavirus vaccine. The company is currently working on five coronavirus projects. It has a bevy of therapies for it, alongside some oncology drugs and analgesics.
The coronavirus vaccine market is currently hot and Sorrento Therapeutics has been speculated to be positioned for success in various categories. Therefore, those who invest in it can ride the price waves.
However, the company lacks sufficient funds in the bank to cover debt obligations in the short run. While it has $24.39 million in cash in the last quarter, its current liabilities are at $91.34 million. The long term debt accounts for $147 million which outweighs $35.54 million trailing revenues.
In general, Sorrento Therapeutics could be at risk of bankruptcy if more stocks are not issued to raise capital. Therefore, investors are advised to keep the company on a watch list and observe how the market reacts.
Many investors might be wondering where to invest his money to earn more and defeat the high inflation following the COVID-19 pandemic and lockdown? As a response, we believe that the biotech or pharmaceutical industry could be highly rewarding. However, high rewarding stocks will also be highly risky, where riding on them may lead to complete loss of capital.
In this article, we have discussed three companies which are currently working on a couple of drug and therapy developments ¬– Jounce Therapeutics, Rubius Therapeutics and Sorrento Therapeutics. If their projects are successful, the stock prices of these companies may shoot up significantly, while failed attempts may lead to a severe loss of invested capital.
Therefore, high risk high reward stocks are not for beginners. Investing in such companies require good experience, ample knowledge and also a bit of luck.
We have conducted extensive research and analysis on over multiple data points on High Risk High Reward Stocks to present you with a comprehensive guide that can help you find the most suitable High Risk High Reward Stocks. Below we shortlist what we think are the best Stocks Investment Platforms after careful consideration and evaluation. We hope this list will assist you in making an informed decision when researching High Risk High Reward Stocks.
Selecting a reliable and reputable online Stocks Investment Platforms trading brokerage involves assessing their track record, regulatory status, customer support, processing times, international presence, and language capabilities. Considering these factors, you can make an informed decision and trade Stocks Investment Platforms more confidently.
Selecting the right online Stocks Investment Platforms trading brokerage requires careful consideration of several critical factors. Here are some essential points to keep in mind:
Our team have listed brokers that match your criteria for you below. All brokerage data has been summarised into a comparison table. Scroll down.
When choosing a broker for Stocks Investment Platforms trading, it's essential to compare the different options available to you. Our Stocks Investment Platforms brokerage comparison table below allows you to compare several important features side by side, making it easier to make an informed choice.
By comparing these essential features, you can choose a Stocks Investment Platforms broker that best suits your needs and preferences for Stocks Investment Platforms. Our Stocks Investment Platforms broker comparison table simplifies the process, allowing you to make a more informed decision.
Here are the top Stocks Investment Platforms.
Compare Stocks Investment Platforms brokers for min deposits, funding, used by, benefits, account types, platforms, and support levels. When searching for a Stocks Investment Platforms broker, it's crucial to compare several factors to choose the right one for your Stocks Investment Platforms needs. Our comparison tool allows you to compare the essential features side by side.
All brokers below are Stocks Investment Platforms. Learn more about what they offer below.
You can scroll left and right on the comparison table below to see more Stocks Investment Platforms that accept Stocks Investment Platforms clients.
Broker | IC Markets | Roboforex | eToro | XTB | XM | Pepperstone | AvaTrade | FP Markets | EasyMarkets | SpreadEx | FXPro |
---|---|---|---|---|---|---|---|---|---|---|---|
Rating | |||||||||||
Regulation | Australian Securities and Investments Commission (ASIC), Financial Services Authority (FSA), Cyprus Securities and Exchange Commission (CySEC) | RoboForex Ltd is regulated by the FSC, license 000138/437, reg. number 128.572. RoboForex Ltd, which is an (A category) member of The Financial Commission, also is a participant of its Compensation Fund | FCA (Financial Conduct Authority) eToro (UK) Ltd (FCA reference 583263), eToro (Europe) Ltd CySEC (Cyprus Securities Exchange Commission), ASIC (Australian Securities and Investments Commission) eToro AUS Capital Limited ASIC license 491139, CySec (Cyprus Securities and Exchange Commission under the license 109/10), FSAS (Financial Services Authority Seychelles) eToro (Seychelles) Ltd license SD076 | FCA (Financial Conduct Authority reference 522157), CySEC (Cyprus Securities and Exchange Commission reference 169/12), FSCA (Financial Sector Conduct Authority), XTB AFRICA (PTY) LTD licensed to operate in South Africa, KPWiG (Polish Securities and Exchange Commission), DFSA (Dubai Financial Services Authority), DIFC (Dubai International Financial Center), CNMV (Comisión Nacional del Mercado de Valores), KNF (Komisja Nadzoru Finansowego), IFSC (Belize International Financial Services Commission license number IFSC/60/413/TS/19) | Financial Services Commission (FSC), Cyprus Securities and Exchange Commission (CySEC), Australian Securities and Investments Commission (ASIC) | Financial Conduct Authority (FCA), Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), Federal Financial Supervisory Authority (BaFin), Dubai Financial Services Authority (DFSA), Capital Markets Authority of Kenya (CMA), Pepperstone Markets Limited is incorporated in The Bahamas (number 177174 B), Licensed by the Securities Commission of the Bahamas (SCB) number SIA-F217 | Australian Securities and Investments Commission (ASIC), ASIC (406684), Financial Services Authority (FSA), South African Financial Sector Conduct Authority (FSCA), Financial Stability Board (FSB), The Financial Services Agency (JAPAN FSA), Financial Futures Association of Japan (FFAJ), Abu Dhabi Global Markets (ADGM), Financial Regulatory Services Authority (FRSA), Polish Financial Supervision Authority (KNF), Israel Securities Association (ISA), British Virgin Islands Financial Services Commission (BVI), BVI (SIBA/L/13/1049), Central Bank of Ireland | Australian Securities and Investments Commission (ASIC), Cyprus Securities and Exchange Commission (CySEC), FSCA (FSP Number 50926), Capital Markets Authority (CMA), Securities Commission of the Bahamas (SCB) | Cyprus Securities and Exchange Commission (CySEC), Australian Securities and Investments Commission (ASIC), Financial Services Authority (FSA), British Virgin Islands Financial Services Commission (BVI) | Financial Conduct Authority (FCA) | Financial Conduct Authority (FCA), Cyprus Securities and Exchange Commission (CySEC), Financial Sector Conduct Authority (FSCA), Securities Commission of the Bahamas (SCB) |
Min Deposit | 200 | 10 | 100 | No minimum deposit | 5 | 200 | 100 | 100 | 100 | 1 | 100 |
Funding |
|
|
|
|
|
|
|
|
|
|
|
Used By | 180,000+ | 1,000,000+ | 30,000,000+ | 935,000+ | 10,000,000+ | 400,000+ | 300,000+ | 10,000+ | 142,500+ | 10,000+ | 1,866,000+ |
Benefits |
|
|
|
|
|
|
|
|
|
|
|
Accounts |
|
|
|
|
|
|
|
|
|
|
|
Platforms | MT4, MT5, Mirror Trader, Web Trader, cTrader, Windows, Mac, iOS, Android | MT4, MT5, Mac, Web Trader, Tablet & Mobile apps | Web Trader, Tablet & Mobile apps | MT4, Mirror Trader, Web Trader, Tablet & Mobile apps | MT4, MT5, Mac, Web Trader, Tablet & Mobile apps | MT4, MT5, TradingView, DupliTrade, myFXbook, Mac, Web Trader, cTrader, Tablet & Mobile apps | Web Trader, MT4, MT5, AvaTradeGo, AvaOptions, DupliTrade, ZuluTrade, Mobile Apps, ZuluTrade, DupliTrade, MQL5 | MT4, MT5, IRESS, Mac, Web Trader, Tablet & Mobile apps | MT4, MT5, Web Trader, TradingView, Tablet & Mobile apps | Web Trader, Tablet & Mobile apps | MT4, MT5, cTrader, Tablet & Mobile apps |
Support |
|
|
|
|
|
|
|
|
|
|
|
Learn More |
Sign
Up with icmarkets |
Sign
Up with roboforex |
Sign
Up with etoro |
Sign
Up with xtb |
Sign
Up with xm |
Sign
Up with pepperstone |
Sign
Up with avatrade |
Sign
Up with fpmarkets |
Sign
Up with easymarkets |
Sign
Up with spreadex |
Sign
Up with fxpro |
Risk Warning | Losses can exceed deposits | Losses can exceed deposits | 76% of retail investor accounts lose money when trading CFDs with this provider. | 76-85% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 72.89% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | 74-89 % of retail investor accounts lose money when trading CFDs | 71% of retail investor accounts lose money when trading CFDs with this provider | Losses can exceed deposits | Your capital is at risk | Losses can exceed deposits | 75.78% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider |
Demo |
IC Markets Demo |
Roboforex Demo |
eToro Demo |
XTB Demo |
XM Demo |
Pepperstone Demo |
AvaTrade Demo |
FP Markets Demo |
easyMarkets Demo |
SpreadEx Demo |
FxPro Demo |
Excluded Countries | US, IR, CA, NZ, JP | AU, BE, BQ, BR, CA, CW, CZ, DE, ES, EE, EU, FM, FR, FI, GW, ID, IR, JP, LR, MP, NL, PF, PL, RU, SE, SJ, SS, SL, SI, TL, TR, DO, US, IT, AT, PT, BG, HR, CY, DK, FL, GR, IE, LV, LT, MT, RO, SK, CH | ZA, ID, IR, KP, BE, CA, JP, SY, TR, IL, BY, AL, MD, MK, RS, GN, CD, SD, SA, ZW, ET, GH, TZ, LY, UG, ZM, BW, RW, TN, SO, NA, TG, SL, LR, GM, DJ, CI, PK, BN, TW, WS, NP, SG, VI, TM, TJ, UZ, LK, TT, HT, MM, BT, MH, MV, MG, MK, KZ, GD, FJ, PT, BB, BM, BS, AG, AI, AW, AX, LB, SV, PY, HN, GT, PR, NI, VG, AN, CN, BZ, DZ, MY, KH, PH, VN, EG, MN, MO, UA, JO, KR, | US, IN, PK, BD, NG , ID, BE, AU | US, CA, IL, IR | AF, AS, AQ, AR, AM, AZ, BY, BE, BZ, BT, BA, BI, CM, CA, CF, TD, CG, CI, ER, GF, PF, GP, GU, GN, GW, GY, HT, VA, IR, IQ, JP, KZ, LB, LR, LY, ML, MQ, YT, MZ, MM, NZ, NI, KP, PS, PR, RE, KN, LC, VC, WS, SO, GS, KR, SS, SD, SR, SY, TJ, TN, TM, TC, US, UY, VU, VG, EH, ES, YE, ZW, ET | BE, BR, KP, NZ, TR, US, CA, SG | US, JP, NZ | US, IL, BC, MB, QC, ON, AF, BY, BI, KH, KY, TD, KM, CG, CU, CD, GQ, ER, FJ, GN, GW, HT, IR, IQ, LA, LY, MZ, MM, NI, KP, PW, PA, RU, SO, SS, SD, SY, TT, TM, VU, VE, YE | US, TR | US, CA, IR |
You can compare Stocks Investment Platforms ratings, min deposits what the the broker offers, funding methods, platforms, spread types, customer support options, regulation and account types side by side.
We also have an indepth Top Stocks Investment Platforms for 2024 article further below. You can see it now by clicking here
We have listed top Stocks Investment Platforms below.
eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.
Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Past performance is not an indication of future results. Trading history presented is less than 5 complete years and may not suffice as basis for investment decision.
Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.
Cryptoasset investing is highly volatile and unregulated in some EU countries. No consumer protection. Tax on profits may apply.
Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.